ArticleBMJ open2021

Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial.

Rob A Vergeer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.